Pharmacokinetics of levofloxacin after oral administration in normal and ketoprofen-treated sheep

The pharmacokinetics of levofloxacin was evaluated in female sheep following its single oral administration (3 mg kg) alone and on concomitant intramuscular (i.m.) administration of ketoprofen (3 mg kg). Levofloxacin concentration was determined using the High Performance Liquid Chromatography. Following oral administration of the drug, mean absorption rate constant (Ka) and mean elimination rate constant () were 1.21  0.19 and 0.13  0.01 h, respectively. The absorption (t1⁄2Ka) and elimination half-life (t1⁄2) were 0.75  0.23 and 5.25  0.21 h, respectively. The mean apparent volume of distribution (Vd(area)), area under plasma drug concentration-time curve (AUC(0 )) and area under first moment curve (AUMC) were 4.35  0.29 L/kg, 2.78  0.21 g.h/mL and 22.54  1.14 g.h/mL, respectively. The mean value of total body clearance (ClB) of the drug was 0.55  0.01 L/h/kg with mean residence time (MRT) of 8.18  0.28 h. The calculated mean value of mean absorption time (MAT) was 6.45  0.26 h. The levofloxacin concentrations from 8 to 24 hrs were significantly higher when ketoprofen was administered along with levofloxacin. However, pharmacokinetic parameters of orally administered levofloxacin were not significantly affected by concomitant administration of ketoprofen in sheep. Oral administration of levofloxacin at 3 mg/kg in sheep resulted in lower concentrations overall thus the drug may be efficacious against bacteria with lower MIC value (0.03

[1]  R. D. Varia,et al.  Pharmacokinetics and bioavailability of ketoprofen after single dose intravenous and intramuscular administration in cattle. , 2014 .

[2]  R. D. Varia,et al.  Disposition Kinetic of Levofloxacin in Experimentally Induced Febrile Model of Sheep , 2012 .

[3]  J. Patel,et al.  Pharmacokinetics of Levofloxacin Following Intravenous and Subcutaneous Administration in Sheep , 2012 .

[4]  A. Gothi,et al.  Effect of moxifloxacin administration on pharmacokinetics of tolfenamic acid in rats , 2011 .

[5]  A. Goudah,et al.  Disposition Kinetics of Levofloxacin in Sheep after Intravenous and Intramuscular Administration , 2010, Veterinary medicine international.

[6]  K. Bhavsar,et al.  Pharmacokinetics of Cefepime Following Intravenous and Intramuscular Administration in Sheep , 2010 .

[7]  U. Patel,et al.  Pharmacokinetics of ceftriaxone in calves. , 2010 .

[8]  Swati,et al.  Disposition of ceftriaxone in goats (Capra hircus). , 2009 .

[9]  U. Patel,et al.  Pharmacokinetics of ceftriaxone in buffalo calves (Bubalus bubalis) following intravenous and intramuscular administration , 2009 .

[10]  R. D. Varia,et al.  Disposition of levofloxacin following oral administration in broiler chickens , 2009 .

[11]  U. Patel,et al.  Single Dose Pharmacokinetics of Cefepime after Intravenous and Intramuscular Administration in Goats , 2008 .

[12]  A. Srivastava,et al.  Kinetic disposition, urinary excretion and dosage regimen of subcutaneously administered levofloxacin in cross bred calves , 2007 .

[13]  V. Dumka Disposition kinetics and dosage regimen of levofloxacin on concomitant administration with paracetamol in crossbred calves , 2007, Journal of veterinary science.

[14]  A. Srivastava,et al.  Disposition Kinetics, Urinary Excretion and Dosage Regimen of Levofloxacin Formulation Following Single Intravenous Administration in Crossbred Calves , 2007, Veterinary Research Communications.

[15]  U. Patel,et al.  PHARMACOKINETICS AND DOSAGE REGIMEN OF CEFEPIME FOLLOWING SINGLE DOSE INTRAVENOUS ADMINISTRATION IN CALVES , 2006 .

[16]  M. Landoni,et al.  Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats. , 2004, Journal of veterinary pharmacology and therapeutics.

[17]  D. Eşsiz,et al.  INFLUENCE OF EXPERIMENTALLY INDUCED TOXOPLASMOSIS (TOXOPLASMA GONDII) ON THE PHARMACOKINETICS OF LEVOFLOXACIN , 2003 .

[18]  M. S. San Andres,et al.  Influence of ruminal distribution on norfloxacin pharmacokinetics in adult sheep. , 2001, Journal of veterinary pharmacology and therapeutics.

[19]  G A Green,et al.  Understanding NSAIDs: from aspirin to COX-2. , 2001, Clinical cornerstone.

[20]  H. Lode,et al.  Levofloxacin Pharmacokinetics and Serum Bactericidal Activities against Five Enterobacterial Species , 2000, Antimicrobial Agents and Chemotherapy.

[21]  D. Bidal,et al.  Enantiospecific pharmacokinetics and pharmacodynamics of ketoprofen in sheep. , 1999, Journal of veterinary pharmacology and therapeutics.

[22]  S. Chien,et al.  Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses , 1997, Antimicrobial agents and chemotherapy.

[23]  D. Fish,et al.  The Clinical Pharmacokinetics of Levofloxacin , 1997, Clinical pharmacokinetics.

[24]  S. Kamerling,et al.  Effects of ketoprofen and phenylbutazone on chronic hoof pain and lameness in the horse. , 1995, Equine veterinary journal.

[25]  G. Riess,et al.  Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals. , 1995, The Journal of antimicrobial chemotherapy.

[26]  S. Kamerling,et al.  Pharmacokinetics of ketoprofen in healthy horses and horses with acute synovitis. , 1995, Journal of veterinary pharmacology and therapeutics.

[27]  R. Davis,et al.  Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. , 1994, Drugs.

[28]  H. Hakusui,et al.  Effects of antacids, ferrous sulfate, and ranitidine on absorption of DR-3355 in humans , 1992, Antimicrobial Agents and Chemotherapy.